Honokiol can inhibit TGF-β/Smad signaling, matrix proteins, and the IL-6/CD44/STAT3 axis to reduce pulmonary fibrosis, which exerts anti-inflammatory and antioxidant effects (Pulivendala et al., 2020). Here, IL6 is linked to pulmonary fibrosis.